Lilly is a global healthcare leader that unites caring with discovery to make life better for people around the world. We were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and today we remain true to that mission in all our work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism

The Indianapolis drug maker announced a very ambitious $90 million program to provide better access to treatment for diabetes, cancer, and tuberculosis. The five year investment called Lily  30x30 and will be going to Brazil, China, India, Kenya, Mexico, Russia, and South Africa. They are also planning on spending some of the money on treating diabetes in Indianapolis.

Lilly estimates that it already reaches 5 million people through the Lilly Global Health Partnership. It will use $45 million of company money and $45 million from the Eli Lilly and Co. Foundation in an effort to expand that reach six fold by 2030.

Lily CEO, John Lechleiter said "it is a fundamental goal of Lily to enable people to get access not only by our medicine but to a better diagnosis and treatments."

Lily also has a plan to develop a program to treat diabetes in Indianapolis. Although the city will represent a small portion of the overall investment, it could benefit on Lily's work in other economically challenged areas.

"Lilly has a strong, 140-year history of improving global health that goes beyond monetary and product donations," said David A. Ricks, Lilly senior vice president, who will assume the role of Lilly president and chief executive officer on January 1, 2017. "As a research-based company, we bring deep scientific and technical expertise to develop better solutions for people around the world. The Lilly Global Health Partnership will enable us to expand our reach in significant and meaningful ways."